Mind Medicine Price Target Maintained With a $36.00/Share by Roth MKM
Mind Medicine Analyst Ratings
Roth MKM Initiates Mind Medicine(MNMD.US) With Buy Rating, Announces Target Price $36
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Baird Starts Mind Medicine (MindMed) With Outperform Rating, $27 Price Target
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
Mind Medicine Analyst Ratings
RBC Lifts Price Target on Mind Medicine (MindMed) to $15 From $14, Notes Imminent Durability Data; Outperform, Speculative Risk Kept
Mind Medicine (MMED) Receives a Buy From Maxim Group
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
Mind Medicine Analyst Ratings